Clinical evaluation of the efficacy and liquid molecular analysis of abemaciclib rechallenge upon progression to abemaciclib combination therapies for ER-positive HER2-negative metastatic breast cancer patients

被引：0
|
作者：
Nishimura, Meiko
Kogawa, Takahiro
Akaishi, Yuko
Ogata, Misato
Masuda, Jun
Terada, Mitsuo
Sakai, Hitomi
Nozawa, Kazuki
Kurozumi, Sasagu
Yokoe, Takamichi
Ozaki, Yukinori Ozaki
Yazaki, Shu
Onishi, Mai
Iwasa, Tsutomu
Onoe, Takuma
Okumura, Yuta
Nakayama, Sayaka
Hagio, Kanako
Takahashi, Yuko
Tanino, Hirokazu
Tsurutani, Junji
Matsumoto, Koji
Shimokawa, Mototsugu
Takano, Toshimi
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-OT2-19-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT2-19-02
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Molecular differences between younger versus older ER-positive and HER2-negative breast cancers
    Qing, Tao
    Karn, Thomas
    Rozenblit, Mariya
    Foldi, Julia
    Marczyk, Michal
    Shan, Naing Lin
    Blenman, Kim
    Holtrich, Uwe
    Kalinsky, Kevin
    Meric-Bernstam, Funda
    Pusztai, Lajos
    NPJ BREAST CANCER, 2022, 8 (01)
  • [42] Molecular differences between younger versus older ER-positive and HER2-negative breast cancers
    Tao Qing
    Thomas Karn
    Mariya Rozenblit
    Julia Foldi
    Michal Marczyk
    Naing Lin Shan
    Kim Blenman
    Uwe Holtrich
    Kevin Kalinsky
    Funda Meric-Bernstam
    Lajos Pusztai
    npj Breast Cancer, 8
  • [43] Axillary Response to Neoadjuvant Therapy in Node-Positive ER-Positive, HER2-Negative Breast Cancer
    Friedman-Eldar, Orli
    Ozmen, Tolga
    Reyes, Fernando Valle
    Goel, Neha
    Tjendra, Youley
    Kesmodel, Susane B.
    Moller, Mecker
    Franceschi, Dido
    Avisar, Eli
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S236 - S236
  • [44] Eribulin monotherapy improved survivals in patients with ER-positive HER2-negative metastatic breast cancer in the real world: a single institutional review
    Watanabe, Junichiro
    SPRINGERPLUS, 2015, 4
  • [45] Efficacy of taxane rechallenge in early metastatic relapse of HER2-negative breast cancer patients previously treated with taxane
    Vasseur, A.
    Carton, M.
    Guiu, S.
    Augereau, P.
    Uwer, L.
    Reynier, M. A. Mouret
    Levy, C.
    Eymard, J- C.
    Goncalves, A.
    Robert, M.
    Rouge, T. De La Motte
    Bachelot, T.
    Petit, T.
    Debled, M.
    Grinda, T.
    Desmoulins, I.
    Vanlemmens, L.
    Dalenc, F.
    Simon, G.
    Cabel, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S501 - S502
  • [46] Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2-Advanced or Metastatic Breast Cancer
    Qureshi, Zaheer
    Jamil, Abdur
    Fatima, Eeshal
    Altaf, Faryal
    Siddique, Rimsha
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2025, 48 (01): : 6 - 15
  • [47] Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
    Masuda, Jun
    Sakai, Hitomi
    Tsurutani, Junji
    Tanabe, Yuko
    Masuda, Norikazu
    Iwasa, Tsutomu
    Takahashi, Masato
    Futamura, Manabu
    Matsumoto, Koji
    Aogi, Kenjiro
    Iwata, Hiroji
    Hosonaga, Mari
    Mukohara, Toru
    Yoshimura, Kiyoshi
    Imamura, Chiyo K.
    Miura, Sakiko
    Yamochi, Toshiko
    Kawabata, Hidetaka
    Yasojima, Hiroyuki
    Tomioka, Nobumoto
    Yoshimura, Kenichi
    Takano, Toshimi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
  • [48] Efficacy of abemaciclib, palbociclib and ribociclib among the older compared with younger women in HR-positive/HER2-negative, advanced breast cancer.
    Landre, Thierry
    Fain, Anna
    Langeron, Emmanuelle
    Mokrane, Lakhdar
    Taleb, Cherifa
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Palbociclib in highly pretreated metastatic ER-positive HER-2 negative breast cancer
    Hoste, Griet
    Punie, Kevin
    Wildiers, Hans
    Neven, Patrick
    Berteloot, Patrick
    Van Nieuwenhuysen, Els
    Han, Sileny
    Concin, Nicole
    Salihi, Rawand
    Lefever, Inge
    Vergote, Ignace
    CANCER RESEARCH, 2018, 78 (04)
  • [50] CD133 Expression in ER-positive/HER2-negative Breast Cancer is Prognostic for Survival
    Huang, J.
    Oshi, M.
    Takabe, K.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S57 - S57
12345